These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16807266

  • 1. Phosphodiesterase 4 inhibition of beta2-integrin adhesion caused by leukotriene B4 and TNF-alpha in human neutrophils.
    Meliton AY, Muñoz NM, Lambertino A, Boetticher E, Learoyd J, Zhu X, Leff AR.
    Eur Respir J; 2006 Nov; 28(5):920-8. PubMed ID: 16807266
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
    Blease K, Burke-Gaffney A, Hellewell PG.
    Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
    [Abstract] [Full Text] [Related]

  • 4. Attenuated translocation of group IVa phospholipase A2 and up-regulated annexin-1 synthesis by glucocorticoid blocks beta 2-integrin adhesion in neutrophils.
    Meliton AY, Munoz NM, Zhu X, Leff AR.
    J Leukoc Biol; 2008 Feb; 83(2):344-51. PubMed ID: 17971499
    [Abstract] [Full Text] [Related]

  • 5. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
    Faisy C, Risse PA, Naline E, Guerot E, Fagon JY, Devillier P, Advenier C.
    Life Sci; 2006 Oct 12; 79(20):1929-35. PubMed ID: 16820175
    [Abstract] [Full Text] [Related]

  • 6. Blockade of LTC4 synthesis caused by additive inhibition of gIV-PLA2 phosphorylation: Effect of salmeterol and PDE4 inhibition in human eosinophils.
    Meliton AY, Muñoz NM, Liu J, Lambertino AT, Boetticher E, Myo S, Myou S, Zhu X, Johnson M, Leff AR.
    J Allergy Clin Immunol; 2003 Aug 12; 112(2):404-10. PubMed ID: 12897749
    [Abstract] [Full Text] [Related]

  • 7. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM, Barnes PJ, Meja K, Giembycz MA.
    Mol Pharmacol; 1995 Oct 12; 48(4):747-57. PubMed ID: 7476903
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM, Barnes PJ, Giembycz MA.
    Cell Biochem Biophys; 1998 Oct 12; 29(1-2):179-201. PubMed ID: 9631245
    [Abstract] [Full Text] [Related]

  • 9. The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
    Ouagued M, Martin-Chouly CA, Brinchault G, Leportier-Comoy C, Depincé A, Bertrand C, Lagente V, Belleguic C, Pruniaux MP.
    Pulm Pharmacol Ther; 2005 Oct 12; 18(1):49-54. PubMed ID: 15607127
    [Abstract] [Full Text] [Related]

  • 10. Blockade of avidity and focal clustering of beta 2-integrin by cysteinyl leukotriene antagonism attenuates eosinophil adhesion.
    Meliton AY, Munoz NM, Leff AR.
    J Allergy Clin Immunol; 2007 Dec 12; 120(6):1316-23. PubMed ID: 17904626
    [Abstract] [Full Text] [Related]

  • 11. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
    Oger S, Méhats C, Barnette MS, Ferré F, Cabrol D, Leroy MJ.
    Biol Reprod; 2004 Feb 12; 70(2):458-64. PubMed ID: 14561639
    [Abstract] [Full Text] [Related]

  • 12. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
    Souza DG, Cassali GD, Poole S, Teixeira MM.
    Br J Pharmacol; 2001 Nov 12; 134(5):985-94. PubMed ID: 11682446
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors.
    Wollin L, Bundschuh DS, Wohlsen A, Marx D, Beume R.
    Pulm Pharmacol Ther; 2006 Nov 12; 19(5):343-52. PubMed ID: 16257550
    [Abstract] [Full Text] [Related]

  • 14. Phosphodiesterase 4 inhibitor cilomilast inhibits fibroblast-mediated collagen gel degradation induced by tumor necrosis factor-alpha and neutrophil elastase.
    Kohyama T, Liu X, Zhu YK, Wen FQ, Wang HJ, Fang Q, Kobayashi T, Rennard SI.
    Am J Respir Cell Mol Biol; 2002 Oct 12; 27(4):487-94. PubMed ID: 12356583
    [Abstract] [Full Text] [Related]

  • 15. The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro.
    Jones NA, Boswell-Smith V, Lever R, Page CP.
    Pulm Pharmacol Ther; 2005 Oct 12; 18(2):93-101. PubMed ID: 15649851
    [Abstract] [Full Text] [Related]

  • 16. Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors.
    Martin-Chouly CA, Astier A, Jacob C, Pruniaux MP, Bertrand C, Lagente V.
    Life Sci; 2004 Jul 02; 75(7):823-40. PubMed ID: 15183075
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
    Derian CK, Santulli RJ, Rao PE, Solomon HF, Barrett JA.
    J Immunol; 1995 Jan 01; 154(1):308-17. PubMed ID: 7995950
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro.
    Hatzelmann A, Schudt C.
    J Pharmacol Exp Ther; 2001 Apr 01; 297(1):267-79. PubMed ID: 11259554
    [Abstract] [Full Text] [Related]

  • 20. Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol.
    Au BT, Teixeira MM, Collins PD, Williams TJ.
    Br J Pharmacol; 1998 Mar 01; 123(6):1260-6. PubMed ID: 9559913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.